Related Experiment Video

Updated: Aug 19, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Huntington's disease, case report

Ante Ivkosic1, Marina Titlic, Tade Tadic

  • 1Split University Hospital, Laboratory for Clinical and Forensic Genetics.

Neurologia I Neurochirurgia Polska
|August 13, 2003
PubMed

Insights

Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG triplet expansion in the HD gene. This paper details a 36-year-old female patient's diagnostic journey, including genetic testing and family pedigree reconstruction.

Area of Science:

  • Neurogenetics
  • Neurology
  • Clinical Diagnostics

Background:

  • Huntington's disease (HD) is a chronic neurodegenerative disorder presenting with chorea, cognitive decline, and behavioral changes.
  • The genetic basis of HD involves an expanded CAG nucleotide triplet repeat within the HD gene, identified on chromosome 4p16.3.
  • Understanding the genetic mutation is crucial for diagnosing and managing this progressive condition.

Observation:

  • This study focuses on a 36-year-old female diagnosed with Huntington's disease.
  • The patient underwent a comprehensive diagnostic evaluation.
  • Diagnostic procedures included detailed clinical assessments and specific genetic testing for the HD mutation.

Findings:

  • Genetic testing confirmed the characteristic CAG triplet expansion, confirming the diagnosis of Huntington's disease.
  • Family pedigree reconstruction provided insights into the inheritance pattern of the disease within the patient's lineage.
  • The diagnostic procedure successfully identified the genetic cause of HD in the patient.

Implications:

  • Accurate genetic diagnosis is essential for effective Huntington's disease management and patient counseling.
  • Pedigree analysis aids in understanding disease transmission and identifying at-risk family members.
  • This case highlights the importance of integrated diagnostic approaches, combining clinical evaluation with genetic testing for neurodegenerative disorders.

More Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...